Results 161 to 170 of about 303,596 (194)
Some of the next articles are maybe not open access.

Effect of orbital wall resection areas in the treatment of patients with endocrine orbitopathy

British Journal of Oral and Maxillofacial Surgery, 2021
Rüdiger Zimmerer   +2 more
exaly  

[Somatostatin receptor scintigraphy in endocrine orbitopathy].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995
Somatostatin receptor scintigraphy with 111In-labeled octreotide proves to be a very sensitive diagnostic tool for evaluation of inflammative activity in endocrine ophthalmopathy (EO). The results of somatostatin receptor scintigraphy (SRS) in 40 patients with EO show a high orbital accumulation of 111In-octreotide in clinically active EO (4 h-median ...
M, Diaz   +5 more
openaire   +1 more source

Effect of the lateral wall valgisation in the treatment of patients with endocrine orbitopathy

British Journal of Oral and Maxillofacial Surgery, 2022
Rüdiger Zimmerer   +2 more
exaly  

[Treat endocrine orbitopathy].

MMW Fortschritte der Medizin, 2023
Christoph, Hintschich   +2 more
openaire   +1 more source

Three-dimensional changes of scleral show after surgical treatment of endocrine orbitopathy

Journal of Cranio-Maxillo-Facial Surgery, 2018
Matthias Krause   +2 more
exaly  

[Thyroid gland function and endocrine orbitopathy].

Klinische Monatsblatter fur Augenheilkunde, 1993
Commonly the Endocrine Orbitopathy (EO) is associated with Graves' disease, but encountered also with Thyroiditis Hashimoto and hypothyroidism. The EO may coincide, precede, or appear during the endocrine dysfunction. EO and thyroid dysfunction are due to an autoimmune process caused by specific immunoglobulins G (IgG).
openaire   +1 more source

Decompression in endocrine orbitopathy with a navigated piezosurgical bone grinder

British Journal of Oral and Maxillofacial Surgery, 2017
I Sterker, T Hierl
exaly  

Home - About - Disclaimer - Privacy